ArticleBMC medical ethics2026
Understanding what shapes patient and family experience of the open disclosure process in the Irish healthcare context: a qualitative study.
Article in BMC medical ethics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Using an evidence-informed co-design approach to develop a mechanism to measure experiences of the open disclosure process: an Irish case study.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhen something goes wrong in healthcare and results in harm or potential harm to the patient, there is an ethical and moral duty for healthcare professionals to disclose the incident to the patient, their family or their relevant others.
objectiveThis study sought to explore experiences of open disclosure and identify aspects of the process that shaped patient/family experience.
designThis research was a retrospective qualitative descriptive study, interviewing those with recent experience of open disclosure. SETTING AND
participantsIn total, 6 patients/family members, 5 healthcare professionals and 5 patient advocates from Ireland took part in semi-structured interviews.
resultsThe results are organised into five themes: (i) The necessity of acknowledgement and apology, (ii) Importance of clear, compassionate and respectful communication, (iii) Openness and sharing as a two-way process, (iv) Healthcare staff as patients in open disclosure, and (v) The lasting impact of poor experiences of open disclosure. Participants emphasised the importance of apology, clear and compassionate communication and the value of creating space during meetings to listen to the experiences of those who have been impacted. It was reported there is a reluctance to use the term ‘open disclosure’ when discussing issues with patients, families and advocates. This may be due to a fear of litigation, fear that being associated with open disclosure means healthcare staff have made a mistake, and/or the existence of a blame culture within organisations. This research also highlighted the experiences of healthcare staff who themselves experience harm. Their experience when colleagues failed to be transparent was described as akin to a double trauma by participants.
conclusionParticipants emphasised key aspects of the process that shaped experience, including quality of communication, openness and the importance of apology and space for sharing experiences. It is evident that compounded harm is happening through poor understanding and implementation of open disclosure, and this is avoidable. Regular feedback from patients and families is important to improve processes and staff training and to ensure the process is meeting the needs of all those involved. PATIENT OR PUBLIC CONTRIBUTION: Patients, patient advocates and experts by experience (those with direct experience of open disclosure) were represented on the steering committee, which guided every phase of this research. They supported the research by providing feedback on study design and recruitment planning, supported sensitive recruitment, helped design the interview guide and reviewed and provided feedback on patient information materials and content forms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.